Once-Daily (od) Fluticasone Furoate/vilanterol (ff/vi: 100/25mcg) Compared With Twice-Daily (bd) Fluticasone Propionate/salmeterol (fsc: 250/50mcg) In Patients With COPD

被引：0
|
作者：
Dransfield, M. T. [1 ]
Crim, C. C. [2 ]
Feldman, G. [3 ]
Korenblat, P. E. [4 ]
Laforce, C. [5 ]
Locantore, N. [2 ]
Pistolesi, M. [6 ]
Watkins, M. [2 ]
Martinez, F. J. [7 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] GlaxoSmithKline, Reseach Triangle Pk, NC USA
[3] South Carolina Pharmaceut Res, Spartanburg, SC USA
[4] Clin Res Ctr LLC, St Louis, MO USA
[5] Carolina Allergy & Asthma, Cary, NC USA
[6] Univ Florence, Florence, Italy
[7] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2432
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
    Dransfield, Mark T.
    Feldman, Gregory
    Korenblat, Phillip
    LaForce, Craig F.
    Locantore, Nicholas
    Pistolesi, Massimo
    Watkins, Michael L.
    Crim, Courtney
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2014, 108 (08) : 1171 - 1179
  • [2] EFFICACY AND SAFETY OF ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL 200/25 MCG COMPARED WITH TWICE-DAILY FLUTICASONE PROPIONATE 500 MCG IN ASTHMA PATIENTS OF ASIAN ANCESTRY
    Lin Jiangtao
    Crawford, Jodie
    Jacques, Loretta
    Stone, Sally
    RESPIROLOGY, 2013, 18 : 111 - 111
  • [3] ADHERENCE WITH ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL COMPARED TO TWICE-DAILY BUDESONIDE/FORMOTEROL OR FLUTICASONE PROPIONATE/SALMETEROL IN ASTHMA
    Averell, C.
    Stanford, R.
    Laliberte, F.
    Wu, J.
    Germain, G.
    Duh, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S39 - S39
  • [4] A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
    Agusti, Alvar
    de Teresa, Luis
    De Backer, Wilfried
    Zvarich, Michael T.
    Locantore, Nicholas
    Barnes, Neil
    Bourbeau, Jean
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (03) : 763 - 772
  • [5] Efficacy And Safety Of Once-Daily Fluticasone Furoate (ff) 50mcg In Adults With Persistent Asthma
    O'Byrne, P. M.
    Woodcock, A.
    Bleecker, E. R.
    Bateman, E. D.
    Lotvall, J.
    Forth, R.
    Medley, H.
    Jacques, L.
    Busse, W. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [6] Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA
    Bernstein, David
    Andersen, Leslie
    Forth, Richard
    Jacques, Loretta
    Yates, Louisa
    JOURNAL OF ASTHMA, 2018, 55 (09) : 984 - 993
  • [7] Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily Fluticasone Propionate/Salmeterol in Patients With Controlled Asthma
    Bernstein, David
    Forth, Richard
    Yates, Louisa
    Andersen, Leslie
    Jacques, Loretta
    CHEST, 2017, 152 (04) : 186A - 186A
  • [8] Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy
    Stynes, Gillian
    Svedsater, Henrik
    Wex, Jaro
    Lettis, Sally
    Leather, David
    Castelnuovo, Emanuela
    Detry, Michelle
    Berry, Scott
    RESPIRATORY RESEARCH, 2015, 16
  • [9] Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy
    Gillian Stynes
    Henrik Svedsater
    Jaro Wex
    Sally Lettis
    David Leather
    Emanuela Castelnuovo
    Michelle Detry
    Scott Berry
    Respiratory Research, 16
  • [10] A Comparison of the Efficacy of Once-Daily Fluticasone Furoate/Vilanterole with Twice-Daily Fluticasone Propionate/Salmeterol in Elderly Asthmatics
    Ishiura, Yoshihisa
    Fujimura, Masaki
    Shiba, Yasutaka
    Ohkura, Noriyuki
    Hara, Johsuke
    Abo, Miki
    Kasahara, Kazuo
    DRUG RESEARCH, 2018, 68 (01) : 38 - 44
12345